Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$484M |
| 2 |
Microsoft
MSFT
|
+$417M |
| 3 |
Amazon
AMZN
|
+$365M |
| 4 |
Apple
AAPL
|
+$357M |
| 5 |
Merck
MRK
|
+$311M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$420M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Philip Morris
PM
|
+$246M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$228M |
| 5 |
Meta Platforms (Facebook)
META
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMTK
3376
DELISTED
DermTech, Inc. Common Stock
DMTK
| $943K | ﹤0.01% |
256,219
+1,795
| +0.7% | +$7.56K |
|
3377
Akebia Therapeutics
AKBA
$354M
| $943K | ﹤0.01% |
1,682,498
| – | – |
|
|
PRPH
3378
DELISTED
ProPhase Labs
PRPH
| $937K | ﹤0.01% |
12,303
| – | – |
|
3379
NLI Holdings
NL
$286M
| $937K | ﹤0.01% |
154,540
+11,842
| +8% | +$82.1K |
|
3380
Kopin
KOPN
$769M
| $934K | ﹤0.01% |
857,089
+68,844
| +9% | +$84.2K |
|
|
SUP
3381
DELISTED
Superior Industries International
SUP
| $933K | ﹤0.01% |
188,514
+919
| +0.5% | +$5.06K |
|
3382
INmune Bio
INMB
$50.8M
| $928K | ﹤0.01% |
143,657
+660
| +0.5% | +$5.32K |
|
3383
Arena Group
AREN
$74.7M
| $926K | ﹤0.01% |
217,974
+13,273
| +6% | +$101K |
|
3384
Natural Gas Services Group
NGS
$479M
| $925K | ﹤0.01% |
89,685
+1
| +0% | +$11 |
|
3385
Inseego
INSG
$126M
| $924K | ﹤0.01% |
158,722
+373
| +0.2% | +$3.31K |
|
3386
Ambev
ABEV
$47B
| $924K | ﹤0.01% |
327,676
+20,591
| +7% | +$53.9K |
|
3387
Scilex Holding
SCLX
$45.5M
| $924K | ﹤0.01% |
3,219
+2,881
| +852% | +$799K |
|
|
KEEL
3388
Keel Infrastructure Corp
KEEL
$2.48B
| $924K | ﹤0.01% |
952,421
+93,445
| +11% | +$87.4K |
|
|
HYPD
3389
Hyperion DeFi Inc
HYPD
$41.4M
| $918K | ﹤0.01% |
3,251
| – | – |
|
|
PLM
3390
DELISTED
PolyMet Mining Corp.
PLM
| $916K | ﹤0.01% |
425,950
+156,494
| +58% | +$389K |
|
3391
Spruce Power Holding Corp
SPRU
$43.2M
| $915K | ﹤0.01% |
139,423
+5,292
| +4% | +$45.3K |
|
|
BCLI
3392
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $910K | ﹤0.01% |
18,380
+133
| +0.7% | +$3.86K |
|
3393
American Resources Corp
AREC
$217M
| $908K | ﹤0.01% |
605,048
| – | – |
|
3394
Stereotaxis
STXS
$141M
| $907K | ﹤0.01% |
444,787
| – | – |
|
3395
Granite Ridge Resources
GRNT
$629M
| $899K | ﹤0.01% |
153,225
+47,626
| +45% | +$322K |
|
|
RMGC
3396
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
| $899K | ﹤0.01% |
89,679
+1,584
| +2% | +$15.9K |
|
|
HIVE
3397
HIVE Digital Technologies
HIVE
$796M
| $899K | ﹤0.01% |
273,124
+20,421
| +8% | +$60.7K |
|
|
NEUE
3398
DELISTED
NeueHealth
NEUE
| $895K | ﹤0.01% |
50,762
+1,412
| +3% | +$72.8K |
|
3399
Twin Disc
TWIN
$346M
| $891K | ﹤0.01% |
92,589
| – | – |
|
|
VIA
3400
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $889K | ﹤0.01% |
48,371
+4,612
| +11% | +$130K |
|
Similar funds
Geode Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Geode Capital Management held 4,968 positions worth $770B, up 8.1% from $713B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.6%. Geode Capital Management opened 69 new positions and exited 162, leaving the 4,968-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2023 buy was GE HealthCare: 6,775,612 shares worth $554M.
- Geode Capital Management added most to Microsoft in Q1 2023, an estimated $417M increase.
- Geode Capital Management's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $420M.
- Geode Capital Management fully exited SVB Financial Group in Q1 2023, selling an estimated $288M.
- Geode Capital Management's ten largest holdings make up 23% of its $770B portfolio in Q1 2023.
- Geode Capital Management opened 69 new positions and closed 162 in Q1 2023.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $770B.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.